Predicting sensitivity of non-small-cell lung cancer to gefitinib: Is there a role for P-Akt Journal Article


Authors: Pao, W.; Miller, V. A.; Venkatraman, E.; Kris, M. G.
Article Title: Predicting sensitivity of non-small-cell lung cancer to gefitinib: Is there a role for P-Akt
Keywords: immunohistochemistry; signal transduction; mitogen activated protein kinase; protein kinase b; cancer survival; protein phosphorylation; treatment outcome; oncoprotein; gene mutation; proto-oncogene proteins; clinical trial; cigarette smoking; raf protein; antineoplastic agents; drug approval; note; drug targeting; antineoplastic agent; protein function; cell proliferation; metabolism; cell survival; gene targeting; enzyme inhibition; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; epidermal growth factor receptor; editorial; receptor, epidermal growth factor; in vitro study; drug effect; enzyme inhibitor; protein serine threonine kinase; protein tyrosine kinase; drug selectivity; phosphatidylinositol 3 kinase; prediction; drug receptor binding; lung tumor; gene expression regulation; gene activation; gene expression regulation, neoplastic; drug antagonism; drug mechanism; enzyme inhibitors; protein-serine-threonine kinases; drug response; proto-oncogene proteins c-akt; gefitinib; tyrosine kinase receptor; prediction and forecasting; predictive value of tests; binding site; lung alveolus cell carcinoma; ras protein; thorax radiography; sex difference; protein-tyrosine kinases; adenosine triphosphate; quinazolines; drug sensitivity; mitogen activated protein kinase kinase; mitogen-activated protein kinase kinases; quinazoline derivative; downstream processing; akt1 protein, human; humans; prognosis; human; priority journal
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 96
Issue: 15
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2004-08-04
Start Page: 1117
End Page: 1119
Language: English
PUBMED: 15292378
PROVIDER: scopus
DOI: 10.1093/jnci/djh244
DOI/URL:
Notes: Cited By (since 1996):28 -- Export Date: 16 June 2014 -- CODEN: JNCIA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Venkatraman Ennapadam Seshan
    382 Seshan
  2. William Pao
    141 Pao
  3. Vincent Miller
    270 Miller
  4. Mark Kris
    869 Kris